Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support services; Warehousing, including dedicated storage, shared warehouses, packing and value-added services, such as labeling and products assembly; Logistics systems, including software for logistics management; Passenger transportation, including transportation of personnel and students; Special services, including rental of bus and vans; Moving, including national and international moving services, and Advertising, including custom transportation services during marketing campaigns. The Company operates through a number of group companies.


PINL:GRPOF - Post by User

Comment by Stocknurseon Feb 18, 2018 10:35am
403 Views
Post# 27580072

RE:RE:Tetra Not Being Bought Out Yet

RE:RE:Tetra Not Being Bought Out YetYes, I agree one needs something concrete to buy. IMO, If you look at this from a risk perspertive there are also some bigger picture items that will substantially increase TBP value once they are sorted out..

1) Pharmacies successfully gaining the right to dispense from stores: https://www.thestar.com/news/gta/2017/11/13/shoppers-drug-mart-seeks-medical-marijuana-brand-manager.html

(Buy-in from pharmacists would be needed as well- which is in our favor as they will need to evidence and information to dispense safely)

2) Movement to a single regulatory system for Cannabis. Physicians do not need to provide "blanket" access once the rec market is legal. They do however need to be able to provide prescriptions and medical advise on specific drugs (strains) with proven medical benefits and safety data. Luckily there are already systems in place for this:


"For this reason, both the Canadian Medical Association (the national association representing physicians) and the Federation of Medical Regulatory Authorities of Canada (the national association representing medical regulators) have expressed clear positions that it is not appropriate for physicians to continue to authorize access to cannabis. These associations believe that the removal of the prohibitions under the CDSA will eliminate the need for the medical access system as it exists today, including the requirements for physician authorization.

They suggest that reasonable access for medical purposes can be met through a single, non-medical system and that patient needs for information and advice could be fulfilled at point of sale by those involved in retail distribution. The medical establishment acknowledges that provisions would need to be made to accommodate minors requiring cannabis for medical purposes, as minors would otherwise be excluded from access.

The medical community also noted that there are cannabinoid-based medicines that meet the regulatory threshold of approval for sale as a prescription drug, meaning that they can be marketed for sale with claims as to safety, efficacy, quality and use for certain conditions. Physicians have standardized information about these drugs and are able to properly advise patients on issues such as interactions with other medication and adverse effects. They point to the presence of these prescription medications as evidence that the existing drug approval process can and should be used moving forward, leading to more cannabis- and cannabinoid-based drugs being prescribed by physicians and dispensed by pharmacists".

Here is an article that speaks to the concerns in another way: https://www.macleans.ca/society/health/why-doctors-dont-want-to-be-the-gatekeepers-of-medical-marijuana/

I am not sure exactly what the regulatory framework will look like once the rec market comes into place, and it will undoubtably change over time-  just some things to think about and to look at when looking at a cannabis company's business model- how prepared are they for a change in regulations/ are they over/under investing in something that is about to change? 


 

<< Previous
Bullboard Posts
Next >>